Initial experience with a direct antithrombin, Hirulog, in unstable angina. Anticoagulant, antithrombotic, and clinical effects.
Rosa María Lidón(Montreal Heart Institute), John M. Maraganore(Biogen (United States)), Martin Juneau(Université de Montréal), Burt Adelman(Unknown), Pierre Théroux(Montreal Heart Institute)
Cited by 102
Related Papers
Pathophysiology of Coronary Artery Disease
|Circulation|2005|2k
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
|New England Journal of Medicine|2015|2k
Vorapaxar in the Secondary Prevention of Atherothrombotic Events
|New England Journal of Medicine|2012|941
Treatment with Bivalirudin (Hirulog) as Compared with Heparin during Coronary Angioplasty for Unstable or Postinfarction Angina
|New England Journal of Medicine|1995|496
High-Intensity Interval Training in Cardiac Rehabilitation
|Sports Medicine|2012|315